TY - JOUR T1 - Social Distancing and Personal Protective Measures Decrease Influenza Morbidity and Mortality JF - medRxiv DO - 10.1101/2020.04.17.20070102 SP - 2020.04.17.20070102 AU - Grant Young AU - Xiaohua Peng AU - Andre Rebeza AU - Santos Bermejo AU - Chang De AU - Lokesh Sharma AU - Charles S. Dela Cruz Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/04/22/2020.04.17.20070102.abstract N2 - Seasonal influenza (flu) is an underappreciated source of disease morbidity and mortality worldwide. While vaccination remains the cornerstone of influenza prevention, common measures practiced during the COVID-19 pandemic such as social distancing, the use of protective face masks, and frequent hand washing are rarely utilized during flu season. In this investigation, we examined the effect of these preventative measures in decreasing influenza burden this year. We examined three countries with major COVID-19 outbreaks i.e. China, Italy and the United States, and compared the flu activity this year to the average of the last 4 years (2015-2019). We found that this year in China and Italy, there was a significantly steeper decline of flu cases than average, which correlated with an increase in positive COVID-19 case reports in those countries. These "averted" cases can be translated into a substantial decrease in morbidity and mortality. As such, we conclude that the current COVID-19 pandemic is a reminder that behavioral measures can decrease the burden of communicable respiratory infections, and these measures should be adopted to an extent during normal influenza season.Competing Interest StatementThe authors have declared no competing interest.Funding StatementN/AAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesPublicly available data https://www.who.int/influenza/gisrs_laboratory/flunet/en/, https://experience.arcgis.com/experience/685d0ace521648f8a5beeeee1b9125cd https://www.who.int/influenza/gisrs_laboratory/flunet/en/ https://experience.arcgis.com/experience/685d0ace521648f8a5beeeee1b9125cd ER -